BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $518,774 | -87.4% | 13,746 | -84.8% | 0.00% | -91.7% |
| Q2 2023 | $4,133,613 | -34.6% | 90,729 | -41.8% | 0.01% | -53.8% |
| Q1 2023 | $6,318,315 | -75.6% | 155,777 | -69.4% | 0.03% | -74.5% |
| Q4 2022 | $25,946,584 | +1494.8% | 509,056 | +1585.6% | 0.10% | +1175.0% |
| Q3 2022 | $1,627,000 | -94.6% | 30,200 | -93.6% | 0.01% | -95.2% |
| Q2 2022 | $30,211,000 | -40.7% | 470,362 | -28.4% | 0.17% | -22.9% |
| Q1 2022 | $50,920,000 | +144.3% | 656,696 | +170.4% | 0.22% | +296.4% |
| Q4 2021 | $20,844,000 | -27.3% | 242,821 | -31.9% | 0.06% | -33.7% |
| Q3 2021 | $28,665,000 | -3.1% | 356,398 | -3.1% | 0.08% | -26.5% |
| Q2 2021 | $29,597,000 | +337.8% | 367,662 | +358.7% | 0.11% | +182.5% |
| Q1 2021 | $6,760,000 | -53.4% | 80,157 | -55.7% | 0.04% | -63.0% |
| Q4 2020 | $14,508,000 | -50.8% | 180,813 | -50.6% | 0.11% | -72.8% |
| Q3 2020 | $29,460,000 | +194.0% | 366,333 | +214.8% | 0.40% | +145.1% |
| Q2 2020 | $10,021,000 | +228.0% | 116,387 | +209.3% | 0.16% | +107.7% |
| Q1 2020 | $3,055,000 | -89.2% | 37,628 | -88.8% | 0.08% | -53.6% |
| Q4 2019 | $28,212,000 | +180.5% | 337,388 | +193.5% | 0.17% | +86.7% |
| Q3 2019 | $10,057,000 | +102.0% | 114,972 | +87.8% | 0.09% | +69.8% |
| Q1 2019 | $4,978,000 | -73.4% | 61,222 | -78.5% | 0.05% | -75.7% |
| Q4 2018 | $18,738,000 | -41.2% | 284,679 | -31.2% | 0.22% | -42.9% |
| Q3 2018 | $31,883,000 | +104.9% | 413,580 | +96.2% | 0.38% | +85.4% |
| Q2 2018 | $15,562,000 | -52.7% | 210,750 | -58.3% | 0.21% | -60.5% |
| Q1 2018 | $32,888,000 | +49.0% | 505,651 | +48.1% | 0.52% | +35.6% |
| Q4 2017 | $22,072,000 | +5914.2% | 341,458 | +5745.9% | 0.38% | +5400.0% |
| Q3 2017 | $367,000 | -88.3% | 5,841 | -88.8% | 0.01% | -88.7% |
| Q2 2017 | $3,146,000 | -57.5% | 51,962 | -63.6% | 0.06% | -69.6% |
| Q1 2017 | $7,410,000 | -5.4% | 142,879 | -19.1% | 0.20% | -36.2% |
| Q4 2016 | $7,829,000 | +35.6% | 176,566 | +45.6% | 0.32% | -16.4% |
| Q3 2016 | $5,773,000 | +957.3% | 121,273 | +904.7% | 0.38% | +1026.5% |
| Q2 2016 | $546,000 | -44.1% | 12,070 | -49.2% | 0.03% | -55.3% |
| Q1 2016 | $977,000 | -15.6% | 23,779 | -21.6% | 0.08% | -40.2% |
| Q4 2015 | $1,158,000 | -73.2% | 30,348 | -77.0% | 0.13% | -88.2% |
| Q3 2015 | $4,327,000 | +1577.1% | 131,722 | +3402.3% | 1.08% | +1100.0% |
| Q1 2015 | $258,000 | – | 3,761 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |